Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis.

Saved in:
Bibliographic Details
Title: Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis.
Authors: Callender VD; Callender Dermatology and Cosmetic Center, Glenn Dale, MD, USA.; Howard University College of Medicine, Washington, DC, USA., Baldwin H; The Acne Treatment and Research Center, Brooklyn, NY, USA.; Robert Wood Johnson University Hospital, New Brunswick, NJ, USA., Gold LS; Henry Ford Hospital, Detroit, MI, USA., Cook-Bolden FE; Fran E. Cook-Bolden, MD, PLLC, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Guenin E; Ortho Dermatologics, Bridgewater, NJ, USA., Alexis AF; Weill Cornell Medicine, New York, NY, USA.
Source: The Journal of dermatological treatment [J Dermatolog Treat] 2025 Dec; Vol. 36 (1), pp. 2480232. Date of Electronic Publication: 2025 Mar 23.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-1753
DOI:10.1080/09546634.2025.2480232